Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020;2(3):e200018.
doi: 10.20900/agmr20200018. Epub 2020 Jul 3.

Centenarians as Models of Resistance and Resilience to Alzheimer's Disease and Related Dementias

Affiliations

Centenarians as Models of Resistance and Resilience to Alzheimer's Disease and Related Dementias

Stacy L Andersen. Adv Geriatr Med Res. 2020.

Abstract

The majority of research to understand the pathogenesis of and contributors to Alzheimer's disease (AD) pathology, dementia, and disease progression has focused on studying individuals who have the disease or are at increased risk of having the disease. Yet there may be much to learn from individuals who have a paradoxical decreased risk of AD suggesting underlying protective factors. Centenarians demonstrate exceptional longevity that for a subset of the cohort is associated with an increased health span characterized by the delay or escape of age-related diseases including dementia. Here, I give evidence of the association of exceptional longevity with resistance and resilience to AD and describe how cohorts of centenarians and their offspring may serve as models of neuroprotection from AD. Discoveries of novel genetic, environmental, and behavioral factors that are associated with a decreased risk of AD may inform the development of interventions to slow or prevent AD in the general population. Centenarian cohorts may also be instrumental in serving as controls to individuals with AD to identify additional risk factors.

Keywords: centenarian; dementia; health span; longevity; neurodegenerative; resilience; resistance.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST The author declares no conflicts of interest.

Figures

Figure 1.
Figure 1.. Centenarians and centenarian offspring who are resistant to Alzheimer’s disease (AD).
This theoretical model shows the expected increase of AD pathology with increasing age (blue solid line). Centenarians who are resistant to AD and therefore avoid both clinical and pathological hallmarks of AD are expected to have negligible levels of AD pathology at the extreme ages of 100+ years (red dotted line). Centenarian offspring who are resistant to AD (orange dashed line) are expected to have a muted effect of resistance to AD due to receiving only half of their genetics from their centenarian parent. This model also demonstrates the added advantage of being able to study centenarian offspring across a wider range of older adulthood relative to centenarian cohorts using longitudinal assessments.
Figure 2.
Figure 2.. Centenarians and centenarian offspring who are resilient to Alzheimer’s disease (AD).
This theoretical model shows the expected declines in cognitive function and/or brain structure integrity associated with increasing levels of AD pathology (blue solid line). Centenarians who are resilient to AD pathology (red dotted line) are expected to exhibit no or only minimal functional and structural changes despite high levels of AD pathology, whereas centenarian offspring who are resilient to AD pathology (orange dashed line) are expected to have a muted effect of resilience due to receiving only half of their genetics from their centenarian parent.

References

    1. Arenaza-Urquijo EM, Vemuri P. Resistance vs resilience to Alzheimer disease: Clarifying terminology for preclinical studies. Neurology. 2018;90(15):695–703. doi: 10.1212/WNL.0000000000005303 - DOI - PMC - PubMed
    1. Andersen SL, Sebastiani P, Dworkis DA, Feldman L, Perls TT. Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span. J Gerontol A Biol Sci Med Sci. 2012;67(4):395–405. doi: 10.1093/gerona/glr223 - DOI - PMC - PubMed
    1. Niccoli T, Partridge L. Ageing as a risk factor for disease. Curr Biol. 2012;22(17):R741–52. doi: 10.1016/j.cub.2012.07.024 - DOI - PubMed
    1. Crimmins EM, Beltran-Sanchez H. Mortality and morbidity trends: is there compression of morbidity? J Gerontol B Psychol Sci Soc Sci. 2011;66(1):75–86. doi: 10.1093/geronb/gbq088 - DOI - PMC - PubMed
    1. DALYs GBD, Collaborators H. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859–922. doi: 10.1016/S0140-6736(18)32335-3 - DOI - PMC - PubMed

LinkOut - more resources